Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

1.6K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effects of trehalose supplementation on bone healing, physical function, and pain in patients with pertrochanteric fractures: a randomized controlled trial.

Scientific reports·2026
Same author

Deep learning in the diagnosis, staging, and prognosis of osteonecrosis of the femoral head: a systematic review.

BMC musculoskeletal disorders·2026
Same author

A Novel Persian Herbal Syrups: Preventive and Curative Effects of Syrup Formulation of Achillea. millefolium L. against Ethylene Glycol Induced Urolithiasis in Rats.

Galen medical journal·2026
Same author

Diagnosis of a peritoneal injury during acetabular fracture surgery using the Stoppa approach: a case report.

Journal of trauma and injury·2026
Same author

2025 ICM: Diagnostic Imaging for Periprosthetic Joint Infection.

The Journal of arthroplasty·2025
Same author

Correction: Effects of trehalose on bone healing, physical function, and pain in patients with pertrochanteric fractures: a randomized controlled trial protocol.

Trials·2025

相关实验视频

Updated: Sep 10, 2025

Preparation of Naringenin Solution for In Vivo Application
08:18

Preparation of Naringenin Solution for In Vivo Application

Published on: August 10, 2021

3.4K

作为抗增殖和抗亡因子的纳林根因 (NG) 对乳腺复合症的ERα和ERβ的影响

Fardad Saremi1,2, Fatemeh Parvin Sabet1, Kimia Nabiee2

  • 1Musculoskeletal Injuries Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Advanced biomedical research
|August 27, 2025
PubMed
概括

在多囊卵巢综合征 (PCOS) 鼠标模型中,纳林因表现出显著的抗氧化和抗炎作用,改善激素平衡和卵巢功能. 这些发现突出了Naringine

关键词:
抗亡因子抗扩散药物毛囊生长纳林根因排卵时间多囊性卵巢综合征

更多相关视频

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.2K

相关实验视频

Last Updated: Sep 10, 2025

Preparation of Naringenin Solution for In Vivo Application
08:18

Preparation of Naringenin Solution for In Vivo Application

Published on: August 10, 2021

3.4K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.2K

科学领域:

  • 生殖内分泌学
  • 生物化学
  • 药理学

背景情况:

  • 多囊卵巢综合征 (PCOS) 是生育年龄妇女普遍存在的内分泌疾病.
  • 这种疾病的特征是雄激素的升高,慢性炎症和氧化应激.
  • 对于生殖健康来说,研究PCOS的治疗药物至关重要.

研究的目的:

  • 评估纳林因 (NAR) 对大鼠PCOS卵巢组织的抗氧化和抗炎因素的治疗作用.
  • 在PCOS模型中评估Naringine对性激素水平和雌激素受体表达的影响.

主要方法:

  • 42只雌性Wistar大鼠被分为对照组和PCOS诱导组,使用不同剂量的Naringine (20 mg/ kg,40 mg/ kg).
  • 干预持续了21天,随后是安乐死和采样.
  • 分析了血清荷尔蒙水平 (雌激素,孕激素,氨) 和卵巢雌激素受体 (ER-α,ER-β) 的基因/蛋白质表达.

主要成果:

  • 纳林林治疗显著增加了总抗氧化能力 (TAC),超氧化脱酶 (SOD) 和谷过氧化酶 (GPX) 的水平.
  • 纳林因降低了甲 (MDA) 水平,表明氧化应激降低.
  • 激素平衡得到改善,雌激素和孕激素增加,氨酸减少;ER-α和ER-β表达也增加.

结论:

  • 纳林因具有强大的抗氧化和抗炎性质.
  • 它有效调节荷尔蒙特征并增强PCOS模型中的雌激素受体表达.
  • 纳林因在生殖和再生医学中表现为有前途的治疗药物.